Shanghai Unveils Policies to Boost Global Biomedical R&D Hub
The Shanghai municipal government has released a set of policies and measures aimed at accelerating...
Policy / Regulatory
China’s CDE, HNMPA, and Bo’ao Lecheng Release Real-world Drug Research Measures
The Center for Drug Evaluation (CDE), Hainan Medical Products Administration (HNMPA), and Bo’Ao Lecheng Medical...
Jiangxi Healthcare Security Administration Launches New VBP Tender
The Jiangxi Healthcare Security Administration (JHSA) has released a notice of a new volume-based procurement...
Jiangxi Leads 22-Province Alliance in VBP for Liver Function Test Reagents
The provincial drug and medical consumables centralized procurement joint meeting office of Jiangxi has released...
CDE Issues Trial Rules for NMPA Drug Review Timekeeping Suspension
The Center for Drug Evaluation (CDE) has released the “NMPA Drug Review Timekeeping Suspension and...
CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
China Updates Hypertension Guidelines, Lowers Diagnostic Threshold
The National Center for Cardiovascular Diseases, the Chinese Medical Doctor Association (CMDA), and other organizations...
China Releases 14th Five-Year Plan for National Health Informatization
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
CDE Seeks Public Feedback on New Drug Benefit-Risk Assessment Guidelines
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Draft Guidelines on New Drug Benefit-Risk Assessment
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Guidelines on Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a Technical Guidelines document focused on “Clinical...
Hainan Free Trade Port to Simplify Drug Import Procedures
The “Provisions on Facilitation of Drug Import in Hainan Free Trade Port,” released in September...
NMPA Proposes ‘Drug Online Sales Blacklist’ for Public Feedback
The National Medical Products Administration (NMPA) has released a draft proposal for a “Drug Online...
Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement
The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has revealed that it has suspended the...
NMPA Suspends GSK’s Avodart Amid Inspection Findings
The National Medical Products Administration (NMPA) has decided to suspend the import, sales, and use...
China’s National Plan to Combat Microbial Drug Resistance Released
The National Health Commission (NHC), Ministry of Education, Ministry of Science and Technology, and 10...
Ortho-K Lenses Included in Hebei’s Volume-Based Procurement List
The drug and medical device procurement center of Hebei Province released a notification regarding the...
Shanghai Launches Inhaled COVID-19 Vaccine Booster Program
On October 25, Shanghai began accepting patient reservations for the inhalable recombinant COVID-19 vaccine (adenovirus...
China’s NMPA Issues New Drug Recall Management Measures
The National Medical Products Administration (NMPA) has released the “Drug Recall Management Measures,” which took...
Fujian Procurement Center Announces VBP for Cardiac and Laparoscopic Medical Consumables
The Fujian drug and device joint procurement center has released two separate notifications regarding the...